Samoilenko, A.V. and Oryshchenko, V.Yu. and Strelchenia, T.N. (2020) Tetranext in the topical treatment of minor recurrent aphthous stomatitis. In: Paradigmatic view on the concept of world science: Collection of scientific papers «Л'ОГОΣ» with Proceedings of the International Scientific and Practical Conference (Vol. 1), August 21, 2020. European Scientific Platform, 2020, Toronto, Canada, pp. 146-149. ISBN 978-0-228-94621-2
Text
2020. Toronto, Canada_P. 146-149.pdf Download (158kB) |
Abstract
Recurrent aphthous stomatitis (RAS) is a very common oral mucosal diseases characterized by solitary or multiple small, round, recurrent oral ulcers surrounded by an erythematous halo. It causes not only pain but could also decrease the quality of life by interfering with swallowing, drinking, eating and even speaking. RAS affects approximately 20% of the general population. It is more common in patients between 10-40 years of age, and predominantly affects women and individuals of higher socioeconomic levels [1]. Clinical trials on new agents with tetracycline as an active ingredient are still ongoing. Therefore, using a similar local drug to assess efficacy could be relevant. The aim of this study was to assess a potential benefit of TetraNext in the treatment of RAS. Fifty-seven patients (33 women and 24 men) who visited the Department of Therapeutic Dentistry of the Dnipropetrovsk Medical Academy with complaints of oral ulcers participated in the study. All patients agreed to participate in the study and therefore they did sign the consent form.
Item Type: | Book Section |
---|---|
Subjects: | Therapeutic dentistry |
Divisions: | Departments > Department of Therapeutic Stomatology |
Depositing User: | Елена Шрамко |
Date Deposited: | 06 Oct 2020 09:46 |
Last Modified: | 06 Oct 2020 09:50 |
URI: | http://repo.dma.dp.ua/id/eprint/5800 |
Actions (login required)
View Item |